Risk factors for delayed healing of neuropathic diabetic foot ulcers: A pooled analysis

Archives of Dermatology

Volumn 136, Issue 12, 2000, Pages 1531-1535

  Margolis, David J ^a   Kantor, Jonathan ^a   Santanna, Jill ^a   Strom, Brian L ^a   Berlin, Jesse A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; CLINICAL TRIAL; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; HUMAN; MEDICAL DECISION MAKING; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEX; TREATMENT PLANNING; WOUND CARE; WOUND HEALING IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS; DIABETIC FOOT; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TIME FACTORS; WOUND HEALING;

EID: 0034529470     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Epidemiology of lower-extremity amputations in the Indian Health Service, 1982-1987
2. Identifying diabetic patients at high risk for lower-extremity amputation in a primary care setting: A prospective evalution of simple screening criteria
3. Incidence, outcomes, and cost of foot ulcers in patients with diabetes
4. A foot risk classification system to predict diabetic amputation in Pima Indians
5. The association between clinical risk factors and outcome of diabetic foot ulcers
6. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: A phase III randomized placebo-controlled double-blind study
7. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers
8. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers
9. Healing of diabetic neuropathic foot ulcers receiving standard treatment: A meta-analysis
10. Foundations of good ulcer care
11. Consensus Development Conference on Diabetic Wound Care: 7-8 April 1999, Boston, Massachusetts
12. Comparing the incidence of lower extremity amputations across the world
13. Causal pathways for incident lowerextremity ulcers in patients with diabetes from two settings
14. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: How great are the risks
15. Chronology and determinants of tissue repair in diabetic lower-extremity ulcers
16. Risk factors for amputation in patients with diabetes mellitus: A case control study
17. Lower-extremity amputation in diabetes: The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers
18. Validation of a diabetic wound classification system: The contribution of depth, infection, and ischemia to risk of amputation
19. A prospective study of risk factors for diabetic foot ulcer
20. The description and classification of diabetic foot lesions
21. Long-term prognosis after healed amputation in patients with diabetes
22. Meta-analysis
23. Heterogeneity, repeated events, and other topics
24. Meta-analysis in clinical trials
25. Bias in meta-analysis detected by a simple, graphical test
26. A statistician looks at meta-analysis
27. Prognostic value of the clinical examination of the diabetic foot ulcer